HEPATIC FUNCTION ABNORMAL
Clinical trials for HEPATIC FUNCTION ABNORMAL explained in plain language.
Never miss a new study
Get alerted when new HEPATIC FUNCTION ABNORMAL trials appear
Sign up with your email to follow new studies for HEPATIC FUNCTION ABNORMAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Liver health and drug safety: new insights on fexinidazole
Knowledge-focused CompletedThis study tested how a single 1200 mg dose of fexinidazole is handled by the body in people with mild or moderate liver impairment compared to those with normal liver function. 21 adults took part to measure drug levels and safety. The goal was to understand if liver problems ch…
Matched conditions: HEPATIC FUNCTION ABNORMAL
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated May 26, 2026 08:59 UTC
-
Liver function and drug safety: new study on venglustat
Knowledge-focused CompletedThis study looked at how the drug venglustat behaves in people with different levels of liver function. 26 adults with mild, moderate, or severe liver impairment, plus healthy volunteers, received a single dose. Researchers measured drug levels in the blood and monitored safety t…
Matched conditions: HEPATIC FUNCTION ABNORMAL
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC